Psychiatry in Parsippany, NJ
8 verified psychiatry doctors in Parsippany.
Psychiatrists are physicians who diagnose and treat mental health conditions, including through medication management.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the New Jersey State Board of Medical Examiners
Dr. Michael Goldin, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jagdish Dang, MD
Psychiatry
CMS Open Payments· $169.60 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$169.60
Total received
2
Transactions
2
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 88th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Jagdish Dang do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shankar Srinivasan, MD
Psychiatry
CMS Open Payments· $38,579 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$38,579
Total received
135
Transactions
16
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total is higher than 99% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Shankar Srinivasan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Robert Parinello, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Samuel Sostre, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Rashminkumar Solanki, MD
Psychiatry
CMS Open Payments· $20.50 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$20.50
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 78th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Rashminkumar Solanki do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Emily Novik, MD
Psychiatry
CMS Open Payments· $33.11 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$33.11
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 57,336 psychiatry doctors we've analyzed, about 24% received any industry payment (median $180 among those who did). This doctor's total ranks around the 80th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US psychiatry doctors.
Payments to Emily Novik do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Jason Carness, MD
Psychiatry
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.